| The effect of F877L and T878A mutations on androgen receptor response to enzalutamide S Prekovic, ME van Royen, ARD Voet, B Geverts, R Houtman, D Melchers, ... Molecular cancer therapeutics 15 (7), 1702-1712, 2016 | 105 | 2016 |
| Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1 L Spans, T Van den Broeck, E Smeets, S Prekovic, B Thienpont, ... Oncotarget 7 (17), 24326, 2016 | 39 | 2016 |
| Validation of the Decipher test for predicting distant metastatic recurrence in men with high-risk nonmetastatic prostate cancer 10 years after surgery T Van den Broeck, L Moris, T Gevaert, L Tosco, E Smeets, N Fishbane, ... European urology oncology 2 (5), 589-596, 2019 | 29 | 2019 |
| The role of TET-mediated DNA hydroxymethylation in prostate cancer E Smeets, AG Lynch, S Prekovic, T Van den Broeck, L Moris, C Helsen, ... Molecular and cellular endocrinology 462, 41-55, 2018 | 19 | 2018 |
| Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer S Prekovic, T Van den Broeck, L Moris, E Smeets, F Claessens, S Joniau, ... Molecular and Cellular Endocrinology 462, 56-63, 2018 | 15 | 2018 |
| The phenotype and function of murine bone marrow-derived dendritic cells is not affected by the absence of VDR or its ability to bind 1α, 25-dihydroxyvitamin D3 AS Vanherwegen, GB Ferreira, E Smeets, Y Yamamoto, S Kato, ... The Journal of Steroid Biochemistry and Molecular Biology 164, 239-245, 2016 | 8 | 2016 |
| Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression. T Van den Broeck, L Moris, T Gevaert, E Smeets, S Prekovic, C Helsen, ... Cancer Research 78 (16), 114-114, 2018 | | 2018 |
| Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through … T Van Den Broeck, L Moris, T Gevaert, S Prekovic, L Tosco, E Smeets, ... European Urology Supplements 17 (2), e84, 2018 | | 2018 |
| A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population T Van Den Broeck, T Gevaert, S Prekovic, K Ong, L Tosco, L Moris, ... European Urology Supplements 3 (16), e837-e838, 2017 | | 2017 |
| The effect of F876L and T877A mutations on androgen receptor response to antagonists S Prekovic, A Voet, M van Royen, B Geverts, A Houtsmuller, D Melchers, ... | | 2015 |
